Early antiretroviral therapy reduces hiv dna following perinatal HIV infection

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection

: The impact of antiretroviral therapy (ART) on the size of the HIV reservoir has implications for virological remission in adults, but is not well characterised in perinatally acquired infection (PaHIV). In a prospective observational study of 20 children with PaHIV and sustained viral suppression...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Foster, C, Pace, M, Kaye, S, Hopkins, E, Jones, M, Robinson, N, Fidler, S, Frater, J, CHERUB Investigators
Formato:	Journal article
Idioma:	English
Publicado em:	Lippincott, Williams & Wilkins 2017

Registros relacionados

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
por: Matthew Pace, et al.
Publicado em: (2022-08-01)

Control of HIV viraemia is not enough in perinatal HIV
por: Caroline Foster, et al.
Publicado em: (2015-07-01)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
por: Martin, GE, et al.
Publicado em: (2017)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
por: Frater, J, et al.
Publicado em: (2019)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
por: Gossez, M, et al.
Publicado em: (2018)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
por: Jakub Kopycinski, et al.
Publicado em: (2023-10-01)

MRI of perinatal HIV infection in the era of antiretroviral therapy
por: M. A. Titova, et al.
Publicado em: (2021-05-01)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: P. Zacharopoulou, et al.
Publicado em: (2022-01-01)

Adults with Perinatally Acquired HIV; Emerging Clinical Outcomes and Data Gaps
por: Merle Henderson, et al.
Publicado em: (2024-04-01)

Short-course antiretroviral therapy in primary HIV infection.
por: Fidler, S, et al.
Publicado em: (2013)

Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
por: Genevieve E. Martin, et al.
Publicado em: (2021-06-01)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
por: Tiraboschi, J, et al.
Publicado em: (2017)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
por: Tiraboschi, J, et al.
Publicado em: (2017)

Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth
por: Trevon Fuller, et al.
Publicado em: (2022-10-01)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
por: A. Yu. Sambyalova, et al.
Publicado em: (2024-07-01)

A cure for HIV: is it in sight?
por: Pace, M, et al.
Publicado em: (2014)

Immunotherapeutic approaches to HIV cure and remission
por: Lee, MJ, et al.
Publicado em: (2021)

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
por: Fidler, S, et al.
Publicado em: (2020)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
por: Thornhill, J, et al.
Publicado em: (2019)

Bone mineral density optimisation in adults with perinatally acquired HIV infection in routine care
por: Thomas J. Pasvol, et al.
Publicado em: (2017-10-01)

Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy
por: Badolato Raffaele, et al.
Publicado em: (2009-08-01)

Childhood lung function following perinatal HIV infection and early antiretroviral therapy initiation: a cross-sectional study
por: Andre Gie, et al.
Publicado em: (2022-03-01)

Hospitalisation rates for youth living with perinatally acquired HIV in England.
por: Sarah May Johnson, et al.
Publicado em: (2024-01-01)

Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.
por: Margaret McManus, et al.
Publicado em: (2016-01-01)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: S. Fidler, et al.
Publicado em: (2021-03-01)

Curing HIV by 'kick and kill': from theory to practice?
por: Pace, M, et al.
Publicado em: (2019)

Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
por: Penelope C. Rose, et al.
Publicado em: (2022-06-01)

Advancing the HIV cure agenda: the next 5 years.
por: Thornhill, J, et al.
Publicado em: (2015)

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
por: Avy Violari, et al.
Publicado em: (2019-01-01)

A randomised controlled trial comparing the impact of Antiretroviral Therapy (ART) with a ‘Kick-and-Kill’ approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial
por: Fidler, S, et al.
Publicado em: (2018)

HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. The HICCUP Study
por: C. Foster, et al.
Publicado em: (2015-07-01)

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
por: Matthew Pace, et al.
Publicado em: (2016-08-01)

Cardioprotective effects of early versus late initiated antiretroviral treatment in adolescents with perinatal HIV-1 infection
por: Itai M. Magodoro, et al.
Publicado em: (2024-06-01)

Malignancy and all-cause mortality; incidence in adolescents and young adults living with perinatally acquired HIV
por: Srishti Chhabra, et al.
Publicado em: (2020-01-01)

HIV-1 drug resistance in primary infections in the UK.
por: Fidler, S, et al.
Publicado em: (2001)

Case series of infertility amongst young women with perinatally acquired HIV: data from a London cohort
por: Jhia Teh, et al.
Publicado em: (2019-01-01)

Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
por: Kaitlin Rainwater-Lovett, et al.
Publicado em: (2017-01-01)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
por: Stöhr, W, et al.
Publicado em: (2013)

Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy
por: Frigati, LJ, et al.
Publicado em: (2020)

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
por: Hamlyn, E, et al.
Publicado em: (2012)